Concourse Financial Group Securities’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Hold
0
9349
2020
Q4
Hold
0
8455
2020
Q3
Hold
0
7866
2020
Q2
Hold
0
7546
2020
Q1
Hold
0
7368
2019
Q4
Hold
0
7253
2019
Q3
Hold
0
7070
2019
Q2
Hold
0
6984